Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems.
Because of this high risk survivors may benefit from surveillance for hearing loss.

Recommendations for surveillance for ototoxicity in survivors who were treated with platinum chemotherapy or radiotherapy to the brain or ear.
Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems.
Because of this high risk survivors may benefit from surveillance for hearing loss.
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Be the first to share your thoughts!

No single cancer diet works for everyone. Your needs shift from chemo to radiation to recovery, and even week to week. T...

Cancer support groups rarely look like the stereotype — and they're not just for patients. This guide covers what actual...

When your oncologist says "no more chemo," the room can go quiet in a way you weren't ready for. You're not sure if you...